Industry Experts

Seng-Lai “Thomas” Tan, Ph.D., is the Chief Scientific Officer at TFC Therapeutics, where he leads discovery and translational biology efforts with a strategic and cross-functional approach. A seasoned drug hunter, Dr. Tan brings deep expertise across therapeutic areas including oncology, immuno-oncology, infectious disease, and autoimmunity. His experience spans biologics and small-molecule development targeting key pathways such as TGFβ, IL-6, TL1A, and the TCR and interferon axes. He is adept at guiding preclinical strategy to support IND-enabling studies, investor communications, and partnership evaluations. Widely recognized in the immunology community, Dr. Tan is a trusted leader, mentor, and collaborative innovator in translational science.